Published in Physician Law Weekly, September 8th, 2004
The company has been in communication, and is cooperating with the United States Securities and Exchange Commission (SEC) regarding these matters.
An independent committee of its board of directors initiated and conducted an investigation of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.